Partnership Opportunities
Meet the Leading Minds in Global CAR-TCR Development
2025 has seen a renewed surge of investment in cell therapy; demonstrated recently in the cases of ArsenalBio and AvenCells, AstraZeneca and Esobiotec, and Bristol Myers Squibb and 2seventy bio. Everyone is looking to put their stake in the market forecast to reach $20.7 billion in 2030.
The industry is actively seeking to evaluate potential partners in order to secure long lasting support across pre-clinical testing and modelling services to improve translatability, through to reducing manufacturing costs to make treatments more accessible for patients.
With this comes the need for global service providers looking to establish or consolidate their footprint. If you are a CDMO building out rapid and reliable manufacturing, a viral vector manufacturer, or pre-clinical and clinical CRO demonstrating cell therapy expertise, analytical service, or working in single cell and sequencing, raw materials and more, our audience wants to hear from you. If you want to position yourself as the leading industry partner in cell therapy, the 10th CAR-TCR Summit is the place to be this September.
Get in touch now to discuss your bespoke package for 2025.
Download The Full Event Guide
Having trouble downloading the brochure?
Let us know here and we’ll email it to you instead.
Audience Breakdown
Discovery
Meet CSOs, CEOs, Pre-clinical Development Scientists, Heads, VPs and Directors of Research and Biology
Our Audience Wants to Meet:
Raw Material Providers, Apheresis/ Blood/ Biospecimen Banks, Genetic Engineering & Genetically Engineered Cell Lines Providers, Antibody Discovery Companies
Translational
Meet Global Heads and Presidents working on translational, pharmacology and biomarker development, and Global Heads of immunology and translational biology
Our Audience Wants to Meet:
CROs, Preclinical Model Providers, Genetic Engineering & Genetically Engineered Cell Lines Providers
Clinical Development
Meet VPs and Heads of Clinical Development, Clinical Trial Leads and Heads of Regulatory Development
Our Audience Wants to Meet:
CROs, Data Management Companies, Software Providers, Legal Firms, Regulatory Consulting Firms
Early-Stage Manufacturing
Meet CTOs, Heads of Process Development and Scientists focused on pre-clinical and early clinical manufacturing
Our Audience Wants to Meet:
CDMO/CMO, Viral & Non-Viral Vector Manufacturers, Equipment Providers, Lab Rental/ Infrastructure Companies, Raw Material Providers
Late-Stage Manufacturing
Meet CTOs, Global Heads of Manufacturing and MSAT Scientists
Our Audience Wants to Meet:
CDMO/CMO, Equipment Providers, Raw Material Providers, Logistics Companies, Transport Companies, Lab Rental/ Infrastructure Companies
Analytical Development
Meet VPs of Quality Control, Heads of Assay Developments and Scientists focusing on Analytical Development
Our Audience Wants to Meet:
Analytical Service Providers, Characterization/ Single Cell/ Sequencing Service Providers, Equipment Providers, Lab Rental/ Infrastructure Companies
Why Should You Prioritize Partnering?
Brand Exposure: Position yourself as the industry’s go-to service provider by showcasing your cutting-edge solutions to a curated audience of senior cell therapy leaders. With leading service providers already confirming their involvement, don’t let your brand be the one to miss out
Thought Leadership: Highlight your contributions to streamlining cell therapy manufacturing or pre-clinical development to our audience of technical and commercial leaders and decision makers
Structured & Bespoke Networking Opportunities: Make valuable connections with decision-makers and scientists to forge new strategic partnerships and consolidate existing relationships
Harness Market Intelligence: As the field continues to evolve, so does the industry’s need for trusted partners. Stay ahead of the curve by gaining invaluable insight into recent trends to ensure your offerings meet their needs
Meet the Who’s Who of CAR-TCR: Gain exclusive access to a diverse audience of 100+ companies including commercial giants alongside pioneering start-ups, comprised of 800+ innovators and decision makers in a collective and collaborative forum
Attending Companies:
Explore Related Events:
Introducing the Cell Therapies Event Series, a collection of 26 established events curated to enable this community to achieve their clinical and commercial potential.
Having trouble downloading the prospectus? Let us know here and we'll email it to you instead.
